nobivac forcat
intervet nederland b.v. - chlamydophila felis (chlamydia psittaci) 10 pfu, feline calicivirus 10 pfu, feline herpesvirus 10 pfu, feline panleucopaenia (infectious enteritis) virus 10 pfu - powder and solvent for suspension for injection - cats non food - feline panleucopenia virus / parvovirus vaccine + feline rhinotracheitis virus vaccine + feline calicivirus vaccine + chlamydia
nobivac forcat
intervet nederland b.v. - chlamydophila felis (chlamydia psittaci) 10 pfu, feline calicivirus 10 pfu, feline herpesvirus 10 pfu, feline panleucopaenia (infectious enteritis) virus 10 pfu - powder and solvent for suspension for injection - cats non food - feline panleucopenia virus / parvovirus vaccine + feline rhinotracheitis virus vaccine + feline calicivirus vaccine + chlamydia
nobivac forcat
intervet nederland b.v. - chlamydophila felis (chlamydia psittaci) 10 pfu, feline calicivirus 10 pfu, feline herpesvirus 10 pfu, feline panleucopaenia (infectious enteritis) virus 10 pfu - powder and solvent for suspension for injection - cats non food - feline panleucopenia virus / parvovirus vaccine + feline rhinotracheitis virus vaccine + feline calicivirus vaccine + chlamydia
nobivac forcat
intervet nederland b.v. - chlamydophila felis (chlamydia psittaci) 10 pfu, feline calicivirus 10 pfu, feline herpesvirus 10 pfu, feline panleucopaenia (infectious enteritis) virus 10 pfu - powder and solvent for suspension for injection - cats non food - feline panleucopenia virus / parvovirus vaccine + feline rhinotracheitis virus vaccine + feline calicivirus vaccine + chlamydia
nobivac tricat trio, lyophilisate and solvent for suspension for injection for cats
msd animal health uk limited - feline calicivirus, feline panleukopenia virus, feline viral rhinotracheitis virus - lyophilisate and solvent for suspension for injection - live viral vaccine - cats
ingelvac prrsflex eu lyophilisate and solvent for suspension for injection for pigs
boehringer ingelheim vetmedica gmbh - attenuated prrs 94881 virus - lyophilisate and solvent for suspension for injection - 104.4 - 106.6 tissue culture infective dose 50% / 1 millilitre - porcine reproductive and respiratory syndrome (prrs) virus
priorix-tetra powder and solvent for solution for injection in pre-filled syringe measles, mumps, rubella and varicella vaccine (live)
glaxosmithkline (ireland) limited - live attenuated measles virus (schwarz strain); live attenuated mumps virus (rit 4385 strain); live attenuated rubella virus (wistar ra 27/3 strain); live attenuated varicella virus (oka strain) - powder and solvent for solution for injection in pre-filled syringe - unknown - measles vaccines; measles, combinations with mumps, rubella and varicella, live attenuated
rotarix oral vaccine
glaxosmithkline nz limited - live attenuated human rotavirus 1e+006 ccid50 ((rix 4414 strain)) - oral suspension - 1e+006 ccid50 - active: live attenuated human rotavirus 1e+006 ccid50 ((rix 4414 strain)) excipient: di-sodium adipate dulbecco's modified eagle medium sucrose water for injection - rotarix is indicated for the prevention of rotavirus gastroenteritis
priorix tetra
glaxo smith kline (israel) ltd - live attenuated measles virus; live attenuated mumps virus; live attenuated rubella virus; live attenuated varicella virus - powder and solvent for solution for injection - live attenuated measles virus 10^ 3.0 ccid50; live attenuated mumps virus 10^ 4.4 ccid50; live attenuated rubella virus 10^ 3.0 ccid50; live attenuated varicella virus 10^ 3.3 pfu - measles, combinations with mumps, rubella and varicella, live attenuated - measles, combinations with mumps, rubella and varicella, live attenuated - priorix-tetra is indicated for active immunisation against measles, mumps, rubella and varicella in children from the age of 12 months up and including 12 years of age.
rotarix suspension
glaxo smith kline (israel) ltd - live attenuated human rotavirus rix4414 strain - suspension - live attenuated human rotavirus rix4414 strain - rota virus, live attenuated - rota virus, live attenuated - rotarix is indicated for the active immunization of infants from the age of 6 weeks for prevention of gastro-enteritis due to rotavirus infection. in clinical trials, efficacy was demonstrated against gastro-enteritis due to rotavirus of types g1p[8], g2p[4], g3p[8], g4p[8] and g9p[8]. the use of rotarix should be based on official recommendations.